News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
215,797 Results
Type
Article (10063)
Company Profile (125)
Press Release (205609)
Section
Business (64797)
Career Advice (1564)
Deals (11270)
Drug Delivery (27)
Drug Development (36633)
Employer Resources (83)
FDA (4985)
Job Trends (5248)
News (118116)
Policy (8777)
Tag
Academia (672)
Alliances (14816)
Alzheimer's disease (378)
Approvals (4980)
Bankruptcy (76)
Best Places to Work (4486)
Biotechnology (84)
Breast cancer (44)
Cancer (481)
Career advice (1278)
Cell therapy (92)
Clinical research (30670)
Collaboration (149)
Compensation (139)
COVID-19 (644)
C-suite (47)
Data (633)
Diabetes (69)
Diagnostics (860)
Earnings (25487)
Employer resources (70)
Events (37952)
Executive appointments (175)
FDA (5279)
Funding (123)
Gene therapy (48)
GLP-1 (196)
Government (913)
Healthcare (4536)
Infectious disease (669)
Inflammatory bowel disease (42)
Interviews (316)
IPO (6152)
Job creations (971)
Job search strategy (1042)
Layoffs (72)
Legal (1256)
Lung cancer (87)
Lymphoma (47)
Manufacturing (82)
Medical device (2102)
Medtech (2103)
Mergers & acquisitions (5241)
Metabolic disorders (179)
Neuroscience (492)
NextGen Class of 2024 (1759)
Non-profit (1064)
Northern California (749)
Obesity (90)
Opinion (67)
People (21284)
Pharmaceutical (44)
Phase I (8792)
Phase II (13677)
Phase III (10518)
Pipeline (241)
Postmarket research (869)
Preclinical (3331)
Radiopharmaceuticals (105)
Rare diseases (103)
Real estate (1596)
Recruiting (40)
Regulatory (7114)
Research institute (507)
Resumes & cover letters (298)
Southern California (639)
Startups (1044)
United States (6183)
Vaccines (111)
Weight loss (40)
Date
Today (50)
Last 7 days (238)
Last 30 days (938)
Last 365 days (14141)
2024 (14079)
2023 (16010)
2022 (20071)
2021 (21730)
2020 (19377)
2019 (14811)
2018 (10907)
2017 (11385)
2016 (10109)
2015 (12202)
2014 (9134)
2013 (6756)
2012 (6856)
2011 (7020)
2010 (6523)
Location
Africa (303)
Asia (15012)
Australia (2203)
California (1591)
Canada (511)
China (168)
Colorado (65)
Connecticut (60)
Delaware (47)
Europe (29587)
Florida (183)
Georgia (55)
Illinois (111)
Indiana (74)
Kansas (51)
Maryland (251)
Massachusetts (1270)
Michigan (43)
Minnesota (70)
New Jersey (607)
New York (559)
North Carolina (317)
Northern California (749)
Ohio (56)
Pennsylvania (374)
South America (360)
Southern California (639)
Texas (217)
Virginia (45)
Washington State (94)
215,797 Results for "sk biopharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SK Biopharmaceuticals Inks Research Collaboration Agreement with ProEn Therapeutics Further Accelerating Expansion of Oncology Research and Pipeline for Global Competitiveness in Radiopharmaceuticals
December 17, 2024
·
4 min read
Press Releases
SK Biopharmaceuticals Seals 1st Actinium-225-Based Collaborative Research Agreement with Korea Institute of Radiological and Medical Sciences as Steps Toward Becoming Global Radiopharmaceutical Therapy Player
November 19, 2024
·
5 min read
SK Biopharmaceuticals Announces 100,000 Patients Globally Have Been Treated with Cenobamate Through Sales of XCOPRI® and ONTOZRY® in the U.S., Europe, Israel, and Canada
SK Biopharmaceuticals Co., Ltd. today announced more than 100,000 patients have been treated globally with cenobamate, an anti-seizure medication (ASM) developed by SK Biopharmaceuticals and its U.S. subsidiary SK Life Science, Inc.
March 11, 2024
·
13 min read
Press Releases
SK pharmteco Unites Leading Brands to Create Global Powerhouse in CDMO Services
December 11, 2024
·
2 min read
Press Releases
SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate
December 13, 2024
·
5 min read
Press Releases
SK Life Science Presents Cenobamate Research at the 2024 American Epilepsy Society (AES) Annual Meeting
November 25, 2024
·
12 min read
News
Full-Life Technologies, SK Biopharmaceuticals Enter Licensing Agreement for Novel Therapeutic Targeting Multiple Solid Tumors
July 16, 2024
·
4 min read
Press Releases
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia
October 24, 2024
·
3 min read
Press Releases
Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines
December 23, 2024
·
6 min read
Press Releases
SK Life Science, Inc. Presents XCOPRI® (cenobamate tablets) CV Data at the AES 2024 Annual Meeting Showing a Deeper Understanding of Cenobamate’s Dual Mechanism of Action
December 9, 2024
·
11 min read
1 of 21,580
Next
